ISSI Shareholder Alert – National Securities Law Firm Seeks Higher Price for Shareholders in Connection with Acquisition. Encourages Shareholders to Contact Law Firm for More Information
March 13, 2015
New York, New York
Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the acquisition of Integrated Silicon Solution Inc. (NASDAQ: “ISSI”) (“ISSI” or the “Company”) on behalf of its shareholders. A Chinese consortium of investors led by Summitview Capital (the “Consortium”), announced that they have entered into a definitive merger agreement under which the Consortium will acquire all of the outstanding shares of ISSI for $19.25 per share in cash.
Our investigation has determined that the offer price of only $19.25 per share unfairly under-values the true going forward inherent value of the Company and that shareholders are not receiving the maximum value for their shares. Indeed, among other things, analysts have projected that ISSI is worth at least $20 per share, and the Company has over $132 million in cash or $4.20 per share in cash on its books. The investigation further seeks to determine whether senior management of ISSI are acting in their own self-interests at the expense of shareholders.
If you are a shareholder of ISSI and would like additional information as to how the acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, please contact us toll free at 1-800-511-7037 or contact us via our website.
Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and, along with its affiliate, has recovered billions of dollars for shareholders in securities actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the “50 Elite Trial Lawyer Firms” and one of the “50 Leading Plaintiff Firms in America.” Attorney advertising. Prior results do not indicate a similar outcome.